
CAPSOVISION INC
CVNASDAQTrading Snapshot
- Day Range
- $6.55 β $6.73
- 52-Week Range
- $3.43 β $15.37
- Volume
- $1.90B
- Avg Volume
- $2.53B
- Shares Outstanding
- 50.0M
- Next Earnings
- Oct 15, 2026
Fundamentals Snapshot
- Annual Revenue
- $14M
- Last Q Revenue
- $3M
- P/E Ratio
- β
- P/S Ratio
- 24.6x
- EPS (TTM)
- $-0.58
- Dividend Yield
- β
Why Investors Own CV
- βHigh-growth profile β revenue up +41.7% YoY with expanding US Equity exposure.
- βHealthy economics β 57% gross margin and 8% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CAPSOVISION INC
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
CAPSOVISION INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CV price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CAPSOVISION INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.